Environmental Engineering Reference
In-Depth Information
References
3. Giannaccini M et al (2014) Non-mammalian vertebrate embryos as models in nanomedicine.
Nanomed Nanotechnol Biol Med 10(4):703-719
4. Soenen SJ et al (2014) The effect of nanoparticle degradation on poly(methacrylic acid)-
coated quantum dot toxicity: the importance of particle functionality assessment in toxicology.
Acta Biomater 10(2):732-741
5. Warheit DB (2008) How meaningful are the results of nanotoxicity studies in the absence of
adequate material characterization? Toxicol Sci 101(2):183-185
6. Gajewicz A et al (2012) Advancing risk assessment of engineered nanomaterials: application
of computational approaches. Adv Drug Deliv Rev 64(15):1663-1693
7. Kanakia S et al (2014) Dose ranging, expanded acute toxicity and safety pharmacology studies
for intravenously administered functionalized graphene nanoparticle formulations. Biomate-
rials 35(25):7022-7031
8. Qinghui Z et al (2014) The nanotoxicity investigation of optical nanoparticles to cultured cells
in vitro. Toxicol Rep 1:137-144
9. Ju L et al (2013) Quantum dot-related genotoxicity perturbation can be attenuated by PEG
encapsulation. Mutat Res 753(1):54-64
10. Kim Y et al (2013) In vivo nanoneurotoxicity screening using oxidative stress and
neuroinflammation paradigms. Nanomed Nanotechnol Biol Med 9(7):1057-1066
11. Shegokar R et al (2011) In vitro protein adsorption studies on nevirapine nanosuspensions for
HIV/AIDS chemotherapy. Nanomed Nanotechnol Biol Med 7(3):333-340
12. Shegokar R, Singh KK (2012) Preparation characterization and cell based delivery of stavu-
dine surface modified lipid nanoparticles. J Nanomed Biotherapeutic Discov 1:192
13. Monteiro-Riviere NA, Inman AO, Zhang LW (2009) Limitations and relative utility of
screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol
Appl Pharmacol 234(2):222-235
14. Long TC et al (2007) Nanosize titanium dioxide stimulates reactive oxygen species in brain
microglia and damages neurons in vitro. Environ Health Perspect 115(11):1631-1637
15. Jones CF, Grainger DW (2009) In vitro assessments of nanomaterial toxicity. Adv Drug Deliv
Rev 61(6):438-456
16. Soenen SJ et al (2013) Turning a frown upside down: Exploiting nanoparticle toxicity for
anticancer therapy. Nano Today 8:121-125
17. Fako VE, Furgeson DY (2009) Zebrafish as a correlative and predictive model for assessing
biomaterial nanotoxicity. Adv Drug Deliv Rev 61(6):478-486
18. http://dx.doi.org/
10.1016/j.biomaterials.2014.04.060
, 2014
19. Shegokar R, M¨ ller RH (2010) Nanocrystals: industrially feasible multifunctional formulation
technology for poorly soluble actives. Int J Pharm 399(1-2):129-139
